EUVIMEDEUVIMED entdecken
Vergleichsstudie

Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease

Shoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, Naoki Hosogaya, Sawana Narita, Shimpei Morimoto, Osamu Kamisawa, Rieko Kiya, Atsushi Katsube, Shingo Yano, Atsushi Kawakami

Drug Discoveries & Therapeutics · 30.04.2026 · 20 (2) · 190-198

DOI: 10.5582/ddt.2026.01000 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 30.04.2026. Verfasst von Shoichi Fukui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Hauptthemen laut MEDLINE: Castleman Disease, Antibodies, Monoclonal, Humanized, Pyridines, Cytokines. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Castleman DiseaseAntibodies, Monoclonal, HumanizedPyridinesCytokinesTriazolesJanus Kinase InhibitorsInterleukin-6 InhibitorsHumansFemaleMaleMiddle AgedInterleukin-6AdultLongitudinal StudiesAgedChemokinesReceptors, Interleukin-6

Stichwörter der Autor:innen

JAK inhibitorbiomarkercytokine profilefilgotinibmulticentric Castleman diseasetocilizumab

Substanzen

Antibodies, Monoclonal, HumanizedPyridinesCytokinestocilizumabGLPG0634TriazolesInterleukin-6Janus Kinase InhibitorsInterleukin-6 InhibitorsChemokines

Autor:innen und Institutionen

  • Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

Zitieren

APA

Fukui, S., Sumiyoshi, R., Koga, T., Hosogaya, N., Narita, S., Morimoto, S., Kamisawa, O., Kiya, R., Katsube, A., Yano, S., & Kawakami, A. (2026). Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease. Drug Discoveries & Therapeutics, 20(2), 190-198. https://doi.org/10.5582/ddt.2026.01000

Vancouver

Fukui S, Sumiyoshi R, Koga T, Hosogaya N, Narita S, Morimoto S, et al. Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease. Drug Discoveries & Therapeutics. 2026;20(2):190-198. doi:10.5582/ddt.2026.01000

BibTeX
@article{Fukui2026,
  author = {Fukui, Shoichi and Sumiyoshi, Remi and Koga, Tomohiro and Hosogaya, Naoki and Narita, Sawana and Morimoto, Shimpei and Kamisawa, Osamu and Kiya, Rieko and Katsube, Atsushi and Yano, Shingo and Kawakami, Atsushi},
  title = {Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease},
  journal = {Drug Discoveries & Therapeutics},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {190--198},
  doi = {10.5582/ddt.2026.01000}
}
Kostenlos starten →